Please use this identifier to cite or link to this item:
|Title:||Interactions of human multidrug resistance protein 4 with camptothecins||Authors:||TIAN QUAN||Keywords:||multidrug resistance, ATP-binding cassette, MRP4, camptothecin, drug transporter, glutathione||Issue Date:||6-Apr-2009||Citation:||TIAN QUAN (2009-04-06). Interactions of human multidrug resistance protein 4 with camptothecins. ScholarBank@NUS Repository.||Abstract:||Multidrug resistance protein 4 (MRP4) is an important member of the MRP family. In this study, we reported that MRP4 is involved in drug resistance to camptothecins (CPTs), which are promising antitumor agents that inhibit the enzyme DNA topoisomerase I. Our goal was to elucidate the role of MRP4 in CPT-related resistance using an extensive panel of its analogs. Cytotoxicity assays suggested that MRP4 overexpression conferred significant resistance to CPTs, and this resistance could be reversed by the glutathione (GSH) synthesis inhibitor buthionine sulfoximine and MRP4 inhibitors including MK571, celecoxib, and diclofenac. In drug accumulation assays, MRP4 significantly decreased the intracellular concentration of most CPT analogs, and MRP4 inhibitors were able to restrain MRP4-mediated drug efflux. Lastly, CPT analogs showed no significant effect on GSH efflux with the exception of CPT-11 at a high concentration. All in all, these novel findings may help us better understand CPT resistance in cancer.||URI:||http://scholarbank.nus.edu.sg/handle/10635/15894|
|Appears in Collections:||Ph.D Theses (Open)|
Show full item record
Files in This Item:
|TianQ.pdf||1.16 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.